Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Journal of the American Society of Cytopathology|February 24, 2024
Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testingLianna H Goetz, Heidi L Evans, Donna Armylagos, et al.The Analyst|February 20, 2014
Desorption electrospray ionization (DESI) with atmospheric pressure ion mobility spectrometry for drug detectionKristyn M Roscioli, Jessica A Tufariello, Xing Zhang, et al.Journal of Molecular Biology|December 14, 2011
A reverse binding motif that contributes to specific protease inhibition by antibodiesEric L Schneider, Melody S Lee, Aida Baharuddin, et al.Biochemistry|July 4, 2007
Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirusD H Goetz, Y Choe, E Hansell, et al.Scientific Reports|April 8, 2025
Variation in defensive and exploratory behaviors across a rattlesnake (Crotalus scutulatus × viridis) hybrid zone in Southwestern new MexicoDylan W Maag, Yannick Z Francioli, Matthew T H Goetz, et al.Bioorganic & Medicinal Chemistry|June 15, 2016
Systematic N-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding networkSimone Sciabola, Gilles H Goetz, Guoyun Bai, et al.The Journal of Biological Chemistry|August 9, 2008
Inhibition of a secreted glutamic peptidase prevents growth of the fungus Talaromyces emersoniiAnthony J O'Donoghue, Cathal S Mahon, David H Goetz, et al.Journal of Medicinal Chemistry|May 29, 2013
Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a toolMarina Shalaeva, Giulia Caron, Yuriy A Abramov, et al.Antiviral Research|August 9, 2011
Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assayYanchen Zhou, Juliet Agudelo, Kai Lu, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 26, 2025
Applications of contemporary tools to measure plasma protein binding of targeted protein degradersMark Niosi, Sam Zhang, Woodrow Burchett, et al.Pageof 7